Insulin appears to shield the brain from toxic proteins associated with Alzheimer's disease, U.S. researchers said on Monday, supporting a theory that Alzheimer's may be a third form of diabetes.
And they said GlaxoSmithKline's (GSK.L) diabetes drug Avandia, or rosiglitazone, which increases sensitivity to insulin, appeared to enhance this protective effect.
